Tazemetostat

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 314 publications

Polycomb Repressive Complex 2 drives flow-sensitive endothelial states underlying vascular inflammation and disease.

Polycomb Repressive Complex 2 drives flow-sensitive endothelial states underlying vascular inflammation and disease.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 31, 2026

Model-dependent GD2 upregulation in Ewing sarcoma with the EZH2 inhibitor tazemetostat: Prerequisites for combination with GD2-specific CAR T cells.

Model-dependent GD2 upregulation in Ewing sarcoma with the EZH2 inhibitor tazemetostat: Prerequisites for combination with GD2-specific CAR T cells.

Journal: Research square
Published: August 01, 2026

Epithelioid Sarcoma: A Review and Update.

Epithelioid Sarcoma: A Review and Update.

Journal: Cancers
Published: July 21, 2026

EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

Journal: Cancer
Published: July 01, 2026

EZH2 Inhibition and Myeloid Risk: A Feature of On-Target Biology.

EZH2 Inhibition and Myeloid Risk: A Feature of On-Target Biology.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 17, 2026

EZH2 Regulates the Proliferation-Senescence Balance and Tumor-Stromal Signaling in Lung Adenocarcinoma.

EZH2 Regulates the Proliferation-Senescence Balance and Tumor-Stromal Signaling in Lung Adenocarcinoma.

Journal: International journal of molecular sciences
Published: June 02, 2026

From design to clinic: Medicinal chemistry and pharmacology of approved epigenetic drugs.

From design to clinic: Medicinal chemistry and pharmacology of approved epigenetic drugs.

Journal: European journal of medicinal chemistry
Published: May 19, 2026

Top2a-dependent neuronal regulation of social behavior and persistent rescue of social deficit through PRC2-mediated epigenetic reprogramming.

Top2a-dependent neuronal regulation of social behavior and persistent rescue of social deficit through PRC2-mediated epigenetic reprogramming.

Journal: bioRxiv : the preprint server for biology
Published: May 13, 2026

Rethinking the PSMA-mediated tumor targeting of nanocarrier and potentiating co-delivery of PARP/EZH2 inhibitors for robust prostate cancer treatment.

Rethinking the PSMA-mediated tumor targeting of nanocarrier and potentiating co-delivery of PARP/EZH2 inhibitors for robust prostate cancer treatment.

Journal: Biomaterials
Published: April 29, 2026

Metastatic Meningioma with Systemic Involvement: Discussion of Molecular, Genomic, and Radiological Features.

Metastatic Meningioma with Systemic Involvement: Discussion of Molecular, Genomic, and Radiological Features.

Journal: World neurosurgery
Published: April 29, 2026

EZH2 Inhibition Remodels Cell States and Enhances EGFRi Sensitization in Bladder Cancer.

EZH2 Inhibition Remodels Cell States and Enhances EGFRi Sensitization in Bladder Cancer.

Journal: European urology oncology
Published: April 13, 2026

The role of EZH2 dysregulation in the pathogenesis of B-cell lymphomas and its implications as a target therapy.

The role of EZH2 dysregulation in the pathogenesis of B-cell lymphomas and its implications as a target therapy.

Journal: Frontiers in oncology
Published: March 30, 2026
Showing 1-12 of 314

Last Updated: 09/26/2026